共 95 条
[1]
Arber DA(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood 127 2391-2405
[2]
Orazi A(2012)Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs J Clin Oncol 30 4098-4103
[3]
Hasserjian R(2016)Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN landmark survey BMC Cancer 16 167-3001
[4]
Thiele J(2012)Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study J Clin Oncol 30 2995-600
[5]
Borowitz MJ(2014)Epidemiology of myeloproliferative neoplasms in the United States Leuk Lymphoma 55 595-944
[6]
Le Beau MM(2011)Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 933-1046
[7]
Emanuel RM(2013)Economic costs of diabetes in the U.S. in 2012 Diabetes Care 36 1033-4432
[8]
Dueck AC(2015)Income losses among cancer survivors: estimates from a national longitudinal survey of American families Cancer 121 4425-365
[9]
Geyer HL(1993)The validity and reproducibility of a work productivity and activity impairment instrument PharmacoEconomics 4 353-446
[10]
Kiladjian JJ(2016)Working after a metastatic cancer diagnosis: factors affecting employment in the metastatic setting from ECOG-ACRIN's symptom outcomes and practice patterns study Cancer 122 438-1572